LSP4-2022 is a novel mGlu4 selective agonist which increases behaviorally bioavailable despair in mouse models of antidepressant action. References: Wozniak M, Golembiowska K, Noworyta-Sokolowska K, Acher F, Cieslik P, Kusek M, Tokarski K, Pilc A, Wierońska JM. Neurochemical and behavioral studies on the 5-HT(1A)-dependent antipsychotic action of the mGlu(4) receptor agonist LSP4-2022. Neuropharmacology. 2016 Jul 25. pii: S0028-3908(16)30278-7. doi: 10.1016/j.neuropharm.2016.06.025. [Epub ahead of print] PubMed PMID: 27465045.

纯度：≥98%

CAS：1413405-33-0